NOVA BIOPHARM AS

1387 ASKER

Finances

Return on Equity

−108,78 %

Current Ratio

7,79

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	159 000	185 000	189 000	309 000
Net Income	−471 000	107 000	−174 000	−41 000
Total Assets	471 000	940 000	845 000	1 236 000
Total Equity	433 000	905 000	797 000	972 000

Income (NOK)	2022	2021	2020	2019
Revenue	159 000	185 000	189 000	309 000
Expenditure	145 000	174 000	155 000	323 000
Operating Profit	14 000	12 000	35 000	−14 000
Financial Income	0	97 000	237 000	5 000
Financial Costs	484 000	2 000	446 000	32 000
Financial Balance	−484 000	95 000	−209 000	−27 000
Earnings Before Tax	−470 000	107 000	−174 000	−41 000
Tax	1 000	0	0	0
Net Income	−471 000	107 000	−174 000	−41 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	175 000	175 000	183 000	190 000
Total Current Assets	296 000	765 000	662 000	1 047 000
Total Assets	471 000	940 000	845 000	1 236 000
Total Retained Equity	333 000	805 000	697 000	872 000
Total Equity	433 000	905 000	797 000	972 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	38 000	35 000	47 000	264 000
Total Equity and Debt	471 000	940 000	845 000	1 236 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	159 000	185 000	189 000	309 000
Other Income	0	0	0	0
Revenue	159 000	185 000	189 000	309 000
Cost of Goods Sold	0	0	0	0
Salary Costs	8 000	2 000	3 000	163 000
Depreciation	0	8 000	7 000	6 000
Impairment	0	0	0	0
Expenditure	145 000	174 000	155 000	323 000
Operating Profit	14 000	12 000	35 000	−14 000
Financial Income	0	97 000	237 000	5 000
Financial Costs	484 000	2 000	446 000	32 000
Financial Balance	−484 000	95 000	−209 000	−27 000
Dividends	0	0	0	0
Net Income	−471 000	107 000	−174 000	−41 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	8 000	15 000
Total Tangible Assets	0	0	8 000	15 000
Total Fiancial Fixed Assets	175 000	175 000	175 000	175 000
Total Fixed Assets	175 000	175 000	183 000	190 000
Stock	0	0	0	0
Total Investments	120 000	634 000	334 000	885 000
Cash, Bank	111 000	101 000	269 000	140 000
Total Current Assets	296 000	765 000	662 000	1 047 000
Total Assets	471 000	940 000	845 000	1 236 000
Total Equity	433 000	905 000	797 000	972 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	0	0	0	0
Unpaid Taxes	33 000	35 000	45 000	73 000
Dividends	0	0	0	0
Other Current Debt	4 000	0	2 000	58 000
Total Current Debt	38 000	35 000	47 000	264 000
Total Equity and Debt	471 000	940 000	845 000	1 236 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−108,78 %	11,82 %	−21,83 %	−4,22 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	8,81 %	6,49 %	18,52 %	−4,53 %
Current Ratio	7,79	21,86	14,09	3,97
Quick Ratio	7,79	21,86	14,09	3,97
Equity Ratio	0,92	0,96	0,94	0,79
Gross Profit Margin	100 %	100 %	100 %	100 %